Items of recent pandemic news: A new, wildly divergent SARS-CoV-2 strain in deer; mental health sequelae in Covid-19 survivors; an update on locating a supply of Paxlovid; new CDC masking guidance; and more. Plus a Ukrainian frippery. Quote of the … Continue reading →
Items of recent pandemic news: Antihistamines may help some long Covid; J&J pauses manufacturing vaccine; FDA authorizes Eli Lilly’s injectable monoclonal; how boosters wane; and a further delay in shots for the youngest children. Plus a frippery. Quote of the … Continue reading →
Items of recent pandemic news: Historical perspective and promising research on long Covid; beginning Omicron-targeted vaccine trials; press attention for a new CBD study; Hong Kong’s zero-Covid strategy and Omicron; and BA.2 in the US. Plus a frippery. Quotes of … Continue reading →
Items of recent pandemic news: A resource for finding authorized therapeutics in the US; how long booster shots protect; an early study isolating ultrapotent antibodies from elite neutralizers; and a new variant on the Omicron variant. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: Simulating an aerosolized virus particle with 1.3 billion atoms via a supercomputer; the first monoclonal antibody treatment authorized for young children; Omicron may be breaking through natural immunity; and molnupiravir’s tepid affirmation. Plus a frippery. … Continue reading →
Items of recent pandemic news: Deer may provide a SARS-CoV-2 reservior; OSHA promulgates rules implementing the Biden administration’s workplace vaccine mandate; and a strong showing for Pfizer’s oral medication against SARS-CoV-2. Plus a frippery. Pfizer’s anti-Covid pill shows strong results … Continue reading →
Items of recent pandemic news: Decisions soon on immunizing kids 5-11 and on boosters for Moderna and J&J; an injectable anti-viral and an oral one; new studies on Delta’s virulence and aerosol transmissibility; plus a frippery. Molnupiravir works The day … Continue reading →
